Arrowhead Pharmaceuticals, Inc.
Pharmaceutical company · Pasadena, California, United States · Nasdaq: ARWR
Arrowhead Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Pasadena, California, United States. Its shares trade on Nasdaq under the ticker ARWR. It has reported private securities offerings to the US SEC, most recently $64 million sold in a notice filed in 2013.
Arrowhead Pharmaceuticals at a glance
What does Arrowhead Pharmaceuticals do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $64 million sold (2013).
Frequently asked questions about Arrowhead Pharmaceuticals
Where is Arrowhead Pharmaceuticals headquartered?
Arrowhead Pharmaceuticals, Inc. is headquartered in Pasadena, California, United States.
What does Arrowhead Pharmaceuticals do?
Arrowhead Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Arrowhead Pharmaceuticals a public company?
Yes. Arrowhead Pharmaceuticals, Inc. trades on Nasdaq under the ticker ARWR.
Similar companies
- Xencor IncPasadena, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.